Caprion Pharmaceuticals' Merger

Caprion Pharmaceuticals raised a round of funding on March 19, 2007. Investors include Thallion Pharmaceuticals.

Caprion's leading and proteomics discovery technologies - CellCarta - enable the discovery of targets for therapeutics development and the identification of protein biomarkers that can reduce risk an…

Articles about Caprion Pharmaceuticals' Merger: